News Image

Is NASDAQ:BLBD suited for growth investing?

By Mill Chart

Last update: Mar 26, 2024

Growth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if BLUE BIRD CORP (NASDAQ:BLBD) is suited for growth investing. Investors should of course do their own research, but we spotted BLUE BIRD CORP showing up in our Louis Navellier growth screen, so it may be worth spending some more time on it.

What matters for growth investors.

  • BLUE BIRD CORP demonstrates a strong Return on Equity(ROE) of 81.07%. This indicates the company's ability to generate favorable returns for shareholders and reflects its efficient utilization of capital. BLUE BIRD CORP shows promising potential for continued success.
  • BLUE BIRD CORP has consistently surpassed EPS estimates in the last 4 quarters, reflecting its strong financial performance and effective management. This trend suggests the company's ability to generate positive earnings surprises and drive shareholder value.
  • With impressive 1-year revenue growth of 33.9%, BLUE BIRD CORP showcases its ability to generate increased sales and revenue. This growth highlights the company's strong customer demand and its effective business strategies.
  • The q2q revenue growth of 34.77% of BLUE BIRD CORP highlights the company's ability to generate incremental revenue and suggests positive market demand for its products or services.
  • The operating margin of BLUE BIRD CORP has seen steady growth over the past year, signaling improved profitability. This trend indicates the company's effective cost management and its ability to generate higher returns.
  • The free cash flow (FCF) of BLUE BIRD CORP has seen steady growth over the past year, indicating enhanced cash flow generation and financial health. This trend underscores the company's effective capital management and its ability to generate sustainable cash flows.
  • The EPS of BLUE BIRD CORP has exhibited growth from one quarter to another (Q2Q), with a 403.0% increase. This underscores the company's ability to generate higher earnings and improve its financial standing.
  • The average next Quarter EPS Estimate for BLUE BIRD CORP has experienced a 51.56% change in the last 3 months, reflecting evolving expectations by analysts regarding the company's EPS performance.
  • In the most recent financial report, BLUE BIRD CORP reported a 403.0% increase in quarterly earnings compared to the previous quarter. This notable growth indicates positive momentum in the company's financials, suggesting an upward trend
  • The earnings per share (EPS) growth of BLUE BIRD CORP are accelerating: the current Q2Q growth of 403.0% is above the previous year Q2Q growth of -329.0%. Earnings momentum and acceleration are key for high growth systems.

Fundamental Analysis Observations

Every day ChartMill assigns a Fundamental Rating to every stock. The score ranges from 0 to 10 and is determined by evaluating multiple fundamental indicators and properties.

Taking everything into account, BLBD scores 5 out of 10 in our fundamental rating. BLBD was compared to 133 industry peers in the Machinery industry. BLBD has an average financial health and profitability rating. An interesting combination arises when we look at growth and value: BLBD is growing strongly while it also seems undervalued. These ratings could make BLBD a good candidate for value and growth investing.

Check the latest full fundamental report of BLBD for a complete fundamental analysis.

More growth stocks can be found in our Lois Navellier screen.

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

BLUE BIRD CORP

NASDAQ:BLBD (4/24/2024, 10:26:57 AM)

35.26

-1.03 (-2.84%)

BLBD News

News Image7 days ago - ChartmillShould you consider BLUE BIRD CORP (NASDAQ:BLBD) for growth investing?

Why the growth investor may take a look at BLUE BIRD CORP (NASDAQ:BLBD).

News Image8 days ago - ChartmillLooking for growth without the hefty price tag? Consider NASDAQ:BLBD.

While growth is established for BLUE BIRD CORP (NASDAQ:BLBD), the stock's valuation remains reasonable.

News Image14 days ago - InvestorPlaceAhead of the Curve: 7 Stocks to Buy Before They Go Mainstream

Discover seven overlooked stocks to buy poised for 10X returns across diverse industries. Unlock their growth potential now.

News Image16 days ago - ChartmillDespite its impressive fundamentals, NASDAQ:BLBD remains undervalued.

Investors should take notice ofBLUE BIRD CORP (NASDAQ:BLBD)—it offers a great deal for the fundamentals it presents.

News Imagea month ago - InvestorPlace7 EV Stocks That Could Be Multibaggers in the Making: March Edition

Discover EV stocks poised for explosive growth, tapping into cutting-edge technology and market dominance.

News Imagea month ago - InvestorPlace3 Promising Small-Cap Stocks Packing a Powerful Punch

Here're three under-the-radar small-cap stocks with robust growth potential that could deliver outsized returns for risk-tolerant investors.

News Image2 months ago - InvestorPlaceBeat Wall Street: 3 Stocks Flying Under the Radar

The market is full of many companies that most people haven’t even heard of. Add these stocks to your portfolio that fly under the radar.

News Image2 months ago - InvestorPlace7 Must-Buy Stocks for a Diversified High-Growth Portfolio

Explore how these high-growth portfolio stocks can drive substantial returns in IT, communication, industrials, and financials.

News Image2 months ago - NewsfileAdaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise

Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - February 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining...

News Image2 months ago - InvestorPlaceWall Street Favorites: 3 EV Stocks With Strong Buy Ratings for February 2024

Though the certainty of the electric vehicle industry may be waning, these three EV stocks offer strong potential nonetheless.

News Image2 months ago - InvestorPlace3 Goliath Growth Stocks Poised for Takeoff in February

These three top-tier growth stocks to buy offer investors incredible potential returns and are perfect for long-term investing.

News Image2 months ago - Seeking AlphaAmerican Securities to sell 4.04M shares in Blue Bird (NASDAQ:BLBD)

Blue Bird announces American Securities affiliate to offer 4.04M shares of common stock, resulting in a 5.55% drop in extended trading.

BLBD Links
Follow us for more